Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-28 @ 9:16 PM
Study NCT ID:
NCT02467504
Status:
COMPLETED
Last Update Posted:
2019-09-09
First Post:
2015-06-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-04
First Submit QC Date:
None
Study First Post Date:
2015-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-09
Results First Submit QC Date:
None
Results First Post Date:
2019-09-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-31
Last Update Post Date:
2019-09-09
Last Update Post Date Type:
ACTUAL